DEFERRARI, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 22.854
AS - Asia 2.108
NA - Nord America 684
SA - Sud America 158
AF - Africa 39
OC - Oceania 2
Totale 25.845
Nazione #
IT - Italia 22.484
SG - Singapore 1.006
US - Stati Uniti d'America 640
CN - Cina 591
VN - Vietnam 295
FR - Francia 188
BR - Brasile 108
HK - Hong Kong 85
CH - Svizzera 43
DE - Germania 42
AR - Argentina 25
MX - Messico 23
FI - Finlandia 21
JP - Giappone 21
GB - Regno Unito 20
BD - Bangladesh 17
IN - India 15
IQ - Iraq 14
ID - Indonesia 11
ZA - Sudafrica 11
NL - Olanda 8
CA - Canada 7
DZ - Algeria 7
IE - Irlanda 7
MA - Marocco 7
PH - Filippine 7
PL - Polonia 7
EC - Ecuador 6
RU - Federazione Russa 6
SC - Seychelles 6
AZ - Azerbaigian 5
CO - Colombia 5
ES - Italia 5
TW - Taiwan 5
UA - Ucraina 5
VE - Venezuela 5
DO - Repubblica Dominicana 4
PK - Pakistan 4
PY - Paraguay 4
SA - Arabia Saudita 4
TR - Turchia 4
DK - Danimarca 3
JO - Giordania 3
KR - Corea 3
NP - Nepal 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BH - Bahrain 2
CL - Cile 2
EG - Egitto 2
IR - Iran 2
KE - Kenya 2
LT - Lituania 2
NI - Nicaragua 2
PA - Panama 2
PR - Porto Rico 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
UZ - Uzbekistan 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BW - Botswana 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
GE - Georgia 1
GT - Guatemala 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
LV - Lettonia 1
ML - Mali 1
MN - Mongolia 1
MT - Malta 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
YT - Mayotte 1
Totale 25.845
Città #
Genova 14.508
Genoa 4.449
Rapallo 2.153
Vado Ligure 1.298
Singapore 507
San Jose 311
Lauterbourg 182
Hanoi 81
Hong Kong 81
Beijing 79
Ho Chi Minh City 78
New York 65
Ashburn 61
Bordighera 51
Zurich 43
Frankfurt am Main 35
Santa Clara 30
Helsinki 21
Tokyo 18
Mexico City 17
Tianjin 16
Los Angeles 14
Da Nang 12
Orem 12
São Paulo 12
Haiphong 11
Baghdad 9
Biên Hòa 7
City of London 7
Council Bluffs 7
Dublin 7
Amsterdam 6
Johannesburg 5
Atlanta 4
Chicago 4
Dallas 4
Guangzhou 4
London 4
Madrid 4
Milan 4
Baku 3
Bắc Ninh 3
Cao Lanh 3
Cardiff 3
Mumbai 3
Orangeburg 3
Quảng Ngãi 3
Rome 3
Shanghai 3
Thái Bình 3
Toronto 3
Tây Ninh 3
Warsaw 3
Amman 2
Bogotá 2
Bologna 2
Buenos Aires 2
Bình Phước 2
Can Tho 2
Chaguanas 2
Conceição do Coité 2
Copenhagen 2
Cotia 2
Denver 2
Des Moines 2
Dhaka 2
Durban 2
Erbil 2
Fortaleza 2
Goiânia 2
Guayaquil 2
Hải Dương 2
Istanbul 2
Jeddah 2
Kathmandu 2
Marseille 2
Montreal 2
Nairobi 2
Nuremberg 2
Phoenix 2
Phủ Lý 2
Porto Alegre 2
Purbalingga 2
Rabat 2
Riyadh 2
San Juan 2
Santo André 2
Santo Domingo 2
Shenzhen 2
Sofia 2
São Gonçalo 2
São João Nepomuceno 2
São Sebastião 2
Taipei 2
Tashkent 2
Thái Nguyên 2
Tirana 2
Wuxi 2
Abreu e Lima 1
Abu Dhabi 1
Totale 24.352
Nome #
L'AMMONIOGENESI RENALE NELL'UOMO 333
Accelerated senescence in the kidneys of patients with type 2 diabetic nephropathy 210
Androgen-mediated apoptosis of kidney tubule cells: role of c-Jun amino terminal kinase 205
ABNORMALITIES IN AMINO ACID METABOLISM IN CHRONIC RENAL FAILURE 196
Chronic kidney disease in hypertension under specialist care: the I-DEMAND study 193
Ambulatory arterial stiffness index and renal abnormalities in primary hypertension 192
Vitamin E-coated filter decreases levels of free 4-hydroxyl-2-nonenal during haemodialysis sessions 185
Increased renal resistive index in patients with essential hypertension: a marker of target organ damage. 182
C-reactive protein and target organ damage in untreated patients with primary hypertension. 176
5,10-Methylenetetrahydrofolate reductase polymorphism and early organ damage in primary hypertension. 175
Interorgan exchange of aminothiols in humans 174
Inter-organ leptin exchange in humans 174
Oxidative stress mediates apoptotic changes induced by hyperglycemia in human tubular kidney cells 171
Abnormal amino acid metabolism after amino acid ingestion in chronic renal failure 167
Correlation between pentosidine and endothelin-1 in subjects undergoing chronic hemodialysis. 166
Changes in renal resistive index and urinary albumin excretion in hypertensive patients under long-term treatment with lisinopril or nifedipine GITS 166
Blood pressure variability and multiple organ damage in primary hypertension 162
Mild hyperuricemia and subclinical renal damage in untreated primary hypertension 162
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy. 161
Subclinical functional and structural renal abnormalities predict new onset type 2 diabetes in patients with primary hypertension 161
Independent association of ECG abnormalities with microalbuminuria and renal damage in hypertensive patients without overt cardiovascular disease: data from Italy-Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. 161
Impact of target organ damage assessment in the evaluation of global risk in patients with essential hypertension. 159
Effects of a protein meal on blood amino acid profile in patients with chronic renal failure. 159
INDIVIDUAZIONE DEL RUOLO DELLA GLUTAMINASI FOSFATO-DIPENDENTE E DELLA GLUTAMINASI FOSFATO-INDIPENDENTE NELLA PRODUZIONE RENALE DI AMMONIACA 158
AMINO ACID METABOLISM AND THE LIVER IN RENAL FAILURE 157
PROTEIN TURNOVER IN THE HUMAN KIDNEY 156
Amino acid imbalance in patients with chronic renal failure. 155
Renal metabolism of amino acids and ammonia in subjects with normal renal function and in patients with chronic renal insufficiency. 155
Mechanisms of renal ammonia production and protein turnover 153
Creatinine clearance and early signs of target organ damage in primary hypertension 152
Nephrin expression is reduced in human diabetic nephropathy: Evidence for a distinct role for glycated albumin and angiotensin II 150
Sub-clinical organ damage in hypertension and obesity 149
Combined effect of albuminuria and estimated glomerular filtration rate on cardiovascular events and all-cause mortality in uncomplicated hypertensive patients 148
Microalbuminuria identifies overall cardiovascular risk in essential hypertension: an artificial neural network-based approach. 148
136) CKD awareness and blood pressare control in the primari care hypertensive population 148
Renal and cardiac abnormalities in primary hypertension 148
Combined use of urinary neutrophil gelatinase-associated lipocalin (uNGAL) and albumin as markers of early cardiac damage in primary hypertension. 148
Metabolic syndrome is associated with early signs of organ damage in nondiabetic, hypertensive patients 148
Increased ambulatory arterial stiffness index is associated with target organ damage in primary hypertension 147
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. I. Studies in the postabsorptive state 147
Arterial hypertension and microalbuminuria in IDDM: the Italian Microalbuminuria Study 147
Inappropriate left ventricular mass is associated with microalbuminuria independently of left ventricular hypertrophy in primary hypertension 147
Predicting cardiovascular risk using creatinine clearance and an artificial neural network in primary hypertension 147
Kidney protein dynamics and ammoniagenesis in humans with chronic metabolic acidosis 146
EFFECTS OF CHRONIC RENAL INSUFFICIENCY AND METABOLIC ACIDOSIS ON GLUTAMINE METABOLISM IN MAN 145
Coronary flow reserve is impaired in hypertensive patients with subclinical renal damage 145
Free and sulfoconjugated catecholamines in normotensive uremic patients: effects of hemodialysis. 144
Apoptosis in the kidneys of patients with type 2 diabetic nephropathy. 144
Mild renal dysfunction and renal vascular resistance in primary hypertension 144
SPLANCHNIC AMINO ACID AND PROTEIN TURNOVER IN HUMANS: INSIGHT FROM ISOTOPE DILUTION AND CATHETERIZATION STUDIES 143
Metabolic syndrome and ambulatory arterial stiffness index in non-diabetic patients with primary hypertension. 143
METABOLIC SYNDROME AND CARDIOVASCULAR RISK IN PRIMARY HYPERTENSION. 142
Phenylalanine hydroxylation across the kidney in humans 141
Renal ammoniagenesis in an early stage of metabolic acidosis in man 141
Muscle protein synthesis and degradation in hemodialysis (HD) patients with protein-energy malnutrition (PEM) 140
Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: role of microalbuminuria. 140
Midwall fractional shortening identifies extracardiac organ damage in essential hypertension 140
Renal metabolism of amino acids in early insulin-dependent diabetes mellitus 140
Microalbuminuria and subclinical cerebrovascular damage in essential hypertension 138
DETERMINANTS OF THE PARTITION OF RENAL AMMONIA PRODUCTION BETWEEN URINE AND VENOUS BLOOD IN MAN WITH METABOLIC ACID-BASE DISTURBANCES 138
Genetic polymorphism of the renin-angiotensin system and organ damage in essential hypertension 137
Renal metabolism of C peptide in type I (insulin-dependent) diabetic patients 137
EFFECTS OF HEMODIALYSIS ON GUANIDINO-PROPIONIC ACID METABOLISM 137
Apoptosis induced by serum withdrawal in human mesangial cells. Role of IGFBP-3 136
Skeletal muscle protein synthesis and degradation in patients with chronic renal failure 136
[Activity of renal enzymes producing ammonia from glutamine in the absence of phosphate: 2. Effect of phosphate dependent glutaminase inhibition by heating]. 135
BRAIN METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL INSUFFICIENCY 134
Cardiovascular and renal risk assessment as a guide for treatment in primary hypertension. 134
Renal ammoniagenesis during the adaptation to metabolic acidosis in man. 134
Abnormalities in amino acid metabolism in patients with chronic renal failure. A pathophysiological approach to the nutritional treatment. II. Studies after amino acid ingestion 134
RENAL METABOLISM OF C-PEPTIDE IN MAN 133
Mild renal dysfunction and cardiovascular risk in hypertensive patients. 133
LEG METABOLISM OF AMINO ACIDS AND AMMONIA IN PATIENTS WITH CHRONIC RENAL FAILURE 133
AMINO ACID BIOSYNTHESIS 132
[Acute effects of peritoneal dialysis on muscle protein turnover]. 132
Disposal of exogenous amino acids by muscle in patients with chronic renal failure 132
Serum uric acid as a marker of target organ damage in primary hypertension 131
EFFETTI DELLE VARIAZIONI DEL pH DEL BAGNO DI DIALISI SULL'EQUILIBRIO ACIDO-BASE (EAB) DEI PAZIENTI IN CORSO DI EMODIALISI 130
Renal ammoniagenesis in humans with chronic potassium depletion 130
Splanchnic exchange of amino acids after amino acid ingestion in patients with chronic renal insufficiency 130
Role of microalbuminuria in the assessment of cardiovascular risk in essential hypertension 130
WHOLE BODY AND ORGAN PROTEIN TURNOVER IN CHRONIC RENAL FAILURE 128
Chronic kidney disease and cardiovascular risk in hypertensive type 2 diabetics: a primary care perspective. 128
Taurine prevents apoptosis induced by high ambient glucose in human tubule renal cells 128
Amino acid metabolism, substrate availability and the control of protein dynamics in the human kidney 127
LEUCINE METABOLISM AND PROTEIN DYNAMICS IN THE HUMAN KIDNEY 127
TT virus infection in haemodialysis patients 127
AMINO ACID METABOLISM IN RENAL FAILURE 127
EFFECT OF AMINO ACID INGESTION ON BLOOD AMINO ACID PROFILE IN PATIENTS WITH CHRONIC RENAL FAILURE 127
Effects of lisinopril and nifedipine on the progression to overt albuminuria in IDDM patients with incipient nephropathy and normal blood pressure 126
MICROALBUMINURIA, CARDIOVASCULAR, AND RENAL RISK IN PRIMARY HYPERTENSION. 126
Serum uric acid levels predict new onset type 2 diabetes in hospitalized patients with primary hypertension: the MAGIC study. 126
Acute effects of peritoneal dialysis with dialysates containing dextrose or dextrose and amino acids on muscle protein turnover in patients with chronic renal failure 126
Ammonia and amino acid metabolism y the portal-vein-drained viscera in chronic renal insufficiency. 126
EFFETTI DELL'INSUFFICIENZA RENALE CRONICA SUL METABOLISMO DELLA TIROSINA E DELLA FENILALANINA. 125
Abnormalities in blood amino acid profile after a protein meal in patients with chronic renal failure. Kidney Int Suppl. 1989 Nov;27:S212-5. 125
Global risk stratification in primary hypertension: the role of the kidney 125
Metabolismo inter-organo dell'omocisteina totale e degli aminoacidi solforati nell'uomo 124
Emerging therapeutic strategies in diabetic nephropathy 124
Abnormalities in blood amino acid profile after a protein meal in patients with chronic renal failure 124
Totale 14.808
Categoria #
all - tutte 75.491
article - articoli 66.273
book - libri 0
conference - conferenze 4.355
curatela - curatele 0
other - altro 680
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.183
Totale 150.982


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021329 0 0 0 0 0 0 0 0 0 111 110 108
2021/20222.592 56 213 142 322 126 187 192 589 69 215 152 329
2022/20232.571 240 115 30 265 421 489 3 238 462 14 248 46
2023/20241.058 66 165 19 108 80 151 43 88 75 9 100 154
2024/20253.055 45 254 86 185 501 322 245 402 142 159 348 366
2025/20264.655 609 109 242 438 688 613 962 253 313 428 0 0
Totale 25.980